日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Corrigendum to Bimekizumab treatment in biologic DMARD-naïve patients with active psoriatic arthritis: 52-week efficacy and safety results from the phase III, randomised, placebo-controlled, active reference BE OPTIMAL study Ann Rheum Dis. 2023;82:1404-1414

关于在未接受过生物制剂DMARD治疗的活动性银屑病关节炎患者中应用Bimekizumab治疗的更正：来自III期随机、安慰剂对照、活性参考BE OPTIMAL研究的52周疗效和安全性结果 Ann Rheum Dis. 2023;82:1404-1414

期刊:Annals of the Rheumatic Diseases
影响因子:20.6
doi:10.1016/j.ard.2025.05.013
Ritchlin, Christopher T; Coates, Laura C; McInnes, Iain B; Mease, Philip J; Merola, Joseph F; Tanaka, Yoshiya; Asahina, Akihiko; Gossec, Laure; Gottlieb, Alice B; Warren, Richard B; Ink, Barbara; Bajracharya, Rajan; Shende, Vishvesh; Coarse, Jason; Landewé, Robert B M
关节炎
银屑病
TIM
发表日期：2026
文献求助 收藏

Relationship of radiographic progression status to low disease activity in patients with PsA receiving secukinumab treatment for 2 years

接受司库奇尤单抗治疗 2 年的银屑病关节炎患者的放射学进展状态与低疾病活动度之间的关系

期刊:Rheumatology
影响因子:4.4
doi:10.1093/rheumatology/keaf488
Mease, Philip J; Coates, Laura C; Gaillez, Corine; Shew, Alexis; Bao, Weibin; Ritchlin, Christopher T
关节炎
银屑病
发表日期：2026
文献求助 收藏

The Function of Efhd1 (+) Telocytes in the Synovial Lymphatic System and Inflammatory-Erosive Arthritis.

Efhd1 (+) 端粒细胞在滑膜淋巴系统和炎症侵蚀性关节炎中的功能。

期刊:
影响因子:
doi:10.1101/2025.11.03.685859
Peng Yue, Mark Kenney H, Kobryn Andriy, Lydon Sean, de Mesy Bentley Karen L, Xing Lianping, Korman Benjamin D, Ritchlin Christopher T, Schwarz Edward M
关节炎
细胞生物学
粒细胞
炎症
发表日期：2026
文献求助 收藏

Psoriatic arthritis: diagnosis, pathogenesis, and emerging therapies

银屑病关节炎：诊断、发病机制和新兴疗法

期刊:Trends in Molecular Medicine
影响因子:13.8
doi:10.1016/j.molmed.2025.05.003
Adamopoulos, Iannis E; Baraliakos, Xenofon; Ritchlin, Christopher
关节炎
银屑病
发表日期：2025
文献求助 收藏

Derivation of a Multivariable Psoriatic Arthritis Risk Estimation Tool (PRESTO): A Step Towards Prevention

多变量银屑病关节炎风险评估工具（PRESTO）的开发：迈向预防的一步

期刊:Arthritis & Rheumatology
影响因子:10.9
doi:10.1002/art.42661
Eder, Lihi; Lee, Ker-Ai; Chandran, Vinod; Widdifield, Jessica; Drucker, Aaron M; Ritchlin, Christopher; Rosen, Cheryl F; Cook, Richard J; Gladman, Dafna D
关节炎
银屑病
REST
发表日期：2025
文献求助 收藏

Guselkumab binding to CD64+ IL-23-producing myeloid cells enhances potency for neutralizing IL-23 signaling

古塞库单抗与产生IL-23的CD64+髓系细胞结合，增强了中和IL-23信号的能力。

期刊:Frontiers in Immunology
影响因子:5.7
doi:10.3389/fimmu.2025.1532852
Kacey L Sachen ，Deepa Hammaker ，Indra Sarabia ，Brian Stoveken ，John Hartman ，Kristin L Leppard ，Nicholas A Manieri ，Phuc Bao ，Carrie Greving ，Eilyn R Lacy ，Matthew DuPrie ，Joshua Wertheimer ，Janise D Deming ，Joseph Brown ，Amy Hart ，He Hurley Li ，Tom C Freeman ，Brice Keyes ，Kristen Kohler ，Ian White ，Nathan Karpowich ，Ruth Steele ，M Merle Elloso ，Steven Fakharzadeh ，Kavitha Goyal ，Frédéric Lavie ，Maria T Abreu ，Matthieu Allez ，Raja Atreya ，Robert Bissonnette ，Kilian Eyerich ，James G Krueger ，Dennis McGonagle ，Iain B McInnes ，Christopher Ritchlin ，Anne M Fourie
IL-2
细胞生物学
CD64
CD6
IL-23
信号转导
发表日期：2025
文献求助 收藏

Uveitis in patients with axial spondyloarthritis or psoriatic arthritis: a post hoc analysis from placebo-controlled phase III studies with secukinumab

中轴型脊柱关节炎或银屑病关节炎患者的葡萄膜炎：一项来自安慰剂对照 III 期司库奇尤单抗研究的事后分析

期刊:Therapeutic Advances in Musculoskeletal Disease
影响因子:4.1
doi:10.1177/1759720X251340255
Brandt-Jürgens, Jan; Rudwaleit, Martin; Behrens, Frank; Ritchlin, Christopher; Peterlik, Daniel; Quebe-Fehling, Erhard; Deodhar, Atul
关节炎
银屑病
发表日期：2025
文献求助 收藏

Tofacitinib Efficacy/Safety in Patients with Ankylosing Spondylitis by Baseline Body Mass Index: A Post Hoc Analysis of Phase 2/3 Trials

托法替尼治疗强直性脊柱炎患者的疗效/安全性（按基线体重指数分层）：一项 2/3 期试验的事后分析

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-024-00726-6
Norton, Hillary; Sliwinska-Stanczyk, Paula; Hala, Tomas; El-Zorkany, Bassel; Stockert, Lori; Mundayat, Rajiv; Wang, Lisy; Ritchlin, Christopher T
强直性脊柱炎
免疫/内分泌
发表日期：2025
文献求助 收藏

Correction: Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies

更正：比美珠单抗治疗银屑病关节炎患者的安全性和有效性：两项3期研究的2年结果

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-025-00761-x
Mease, Philip J; Merola, Joseph F; Tanaka, Yoshiya; Gossec, Laure; McInnes, Iain B; Ritchlin, Christopher T; Landewé, Robert B M; Asahina, Akihiko; Ink, Barbara; Heinrichs, Andrea; Bajracharya, Rajan; Shende, Vishvesh; Coarse, Jason; Coates, Laura C
关节炎
银屑病
发表日期：2025
文献求助 收藏

Summary of Research: Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies

研究总结：比美珠单抗治疗银屑病关节炎患者的安全性和有效性：两项3期研究的2年结果

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-025-00764-8
Mease, Philip J; Merola, Joseph F; Tanaka, Yoshiya; Gossec, Laure; McInnes, Iain B; Ritchlin, Christopher T; Landewé, Robert B M; Asahina, Akihiko; Ink, Barbara; Heinrichs, Andrea; Bajracharya, Rajan; Shende, Vishvesh; Coarse, Jason; Coates, Laura C
关节炎
银屑病
发表日期：2025
文献求助 收藏